If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpirax-Sarco Regulatory News (SPX)

Share Price Information for Spirax-Sarco (SPX)

Share Price is delayed by 15 minutes
Get Live Data
6,395.00    95.00 (1.51%)
Bid:
6,380.00
Ask:
6,390.00
Spread: 10.00 (0.157%)
Market Cap: £4.72b
SPX Live PriceLast checked at - London Stock Exchange

Intraday Spirax-Sarco Share Chart

AGM Statement - Trading Update

15 May 2018 07:00

RNS Number : 0291O
Spirax-Sarco Engineering PLC
15 May 2018
 

 

 

News Release

 

Tuesday 15th May 2018

AGM Statement - TRADING UPDATE

Overall expectations unchanged, acquisitions continue to perform in line with plan

 

Spirax-Sarco Engineering plc, the world leader in the control and efficient use of steam, electrical thermal energy solutions and peristaltic pumping and associated fluid path technologies, issues the following trading update in respect of the period ended 30th April 2018.

 

Economic environment

The global macro-economic environment for the Group remains positive with global Industrial Production (IP) growth for 2018 forecast to be very similar to that achieved in 2017.

 

Trading

In line with the macro-economic environment and as anticipated at the time of our preliminary announcement in March, organic* sales growth for the Group in the first four months of the year has been very similar to the first four months of 2017 for both the Steam Specialties and Watson-Marlow businesses. Within the Steam Specialties business we have seen improved growth in the Americas, while growth has been lower in Asia Pacific and EMEA, albeit both segments had a very strong start to the year in 2017. Watson-Marlow continues to see growth in EMEA, Asia Pacific and the Americas.

 

The integration of the two acquisitions made in 2017, Gestra which was acquired in May and Chromalox which joined the Group in July, is progressing to schedule and the businesses continue to perform in line with their respective acquisition plans.

 

As expected, the currency tailwind that we experienced in the last two years has become a headwind in the current year. Since the announcement of our preliminary results in March, sterling has strengthened slightly against the basket of currencies we trade in. If April's foreign exchange rates were to continue for the rest of the year we would expect to see a reduction in sales and profits due to currency movements of 3% and 5% respectively. Movements in exchange rates are often volatile and unpredictable, therefore the actual impact could be significantly different.

 

On an organic, constant currency basis, Group operating profit is ahead of the comparable four-month period in 2017 and we continue to prioritise investments for growth over further margin expansion.

 

 

Financial position

Our business remains highly cash generative and we maintain a strong balance sheet. At 30th April 2018 net debt was £345 million. There has been no material change in the financial position of the Group during the period.

 

 

Outlook

We have good diversification across market sectors and geographic regions, and remain focused on the rigorous implementation of our strategies for growth. While, as normal, our short order book continues to provide only limited visibility, the Group's fundamental strengths stand us in good stead to continue to deliver growth that outperforms our markets.

 

Organic sales growth in the first four months has been very much as anticipated and is consistent with that experienced in the same period in the prior year. With forecasts for Industrial Production growth rates for 2018 also similar to those seen in 2017 our overall expectations of organic growth and trading margins for the full-year are unchanged to those set out in our preliminary announcement in March. Provided there is no material deterioration in trading conditions the Board has confidence that the Group will make further progress in 2018.

 

Spirax-Sarco Engineering plc expects to publish its 2018 half-year results on Wednesday 8th August 2018.

 

Enquiries:

Nicholas Anderson, Chief Executive

Kevin Boyd, Group Finance Director

Tel: 01242 535234

 

 

* References to organic changes are excluding acquisitions and disposals, and are expressed at constant currency.

References to profit are to adjusted profit that excludes the amortisation and impairment of acquisition-related intangible assets and acquisition and disposal costs, together with the tax effects of these items.

 

About SpiraxSarco Engineering plc

SpiraxSarco Engineering plc comprises two worldleading businesses, Spirax Sarco for steam and electrical thermal energy solutions and WatsonMarlow Fluid Technology Group for niche peristaltic pumps and associated fluid path technologies.  Spirax Sarco provides a broad range of fluid control and electrical process heating products, engineered packages, site services and systems expertise for a diverse range of industrial and institutional customers. The business helps its end users to improve production efficiency, reduce energy costs, water usage and emissions, improve product quality and enhance the safety of their operations. WatsonMarlow Fluid Technology Group offers the ideal solution for a wide variety of demanding fluid path applications with highly accurate, controllable and virtually maintenance free pumps and associated technologies.  The Group is headquartered in Cheltenham, England, has strategically located manufacturing plants around the world and employs over 7,250 people, of whom approximately 1,600 are direct sales and service engineers. Its shares have been listed on the London Stock Exchange since 1959 (symbol: SPX).

 

Further information can be found at www.spiraxsarcoengineering.com

 

RNS filter: Inside information prior to release

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMGGUCUAUPRGQC
Date   Source Headline
10th Jun 20162:59 pmRNSHolding(s) in Company
2nd Jun 20164:20 pmRNSAdditional Listing
2nd Jun 20163:28 pmRNSDirector/PDMR Shareholding
1st Jun 20169:45 amRNSTotal Voting Rights
31st May 20165:22 pmRNSDirector Declaration
10th May 20164:48 pmRNSResult of AGM
10th May 20167:00 amRNSAGM Statement - Trading Update
6th May 20169:46 amRNSTotal Voting Rights
6th May 20169:45 amRNSHolding(s) in Company
6th May 20169:45 amRNSHolding(s) in Company
15th Apr 20162:00 pmRNSDirector/PDMR Shareholding
24th Mar 20164:38 pmRNSDirector/PDMR Shareholding
22nd Mar 201611:21 amRNSTotal Voting Rights
21st Mar 20162:15 pmRNSAnnual Report 2015 & Notice of AGM
15th Mar 201610:11 amRNSDisclosure of Home Member State
9th Mar 201612:34 pmRNSDirector/PDMR Shareholding
3rd Mar 20167:00 amRNSFinal Results 2015
23rd Feb 201611:05 amRNSTotal Voting Rights
29th Jan 20169:10 amRNSBlocklisting Interim Review
22nd Jan 20168:21 amRNSTotal Voting Rights
6th Jan 201612:36 pmRNSHolding(s) in Company
22nd Dec 20159:27 amRNSTotal Voting Rights
8th Dec 201510:21 amRNSHolding(s) in Company
3rd Dec 201511:09 amRNSDirector/PDMR Shareholding
2nd Dec 20158:18 amRNSHolding(s) in Company
26th Nov 20152:01 pmRNSHolding(s) in Company
26th Nov 20151:58 pmRNSHolding(s) in Company
25th Nov 20159:00 amRNSAcquisition
24th Nov 20152:50 pmRNSHolding(s) in Company
23rd Nov 20151:31 pmRNSTotal Voting Rights
19th Nov 20153:18 pmRNSHolding(s) in Company
19th Nov 20153:13 pmRNSHolding(s) in Company
17th Nov 20157:00 amRNSTrading Update
10th Nov 20152:38 pmRNSDirector/PDMR Shareholding
6th Nov 20152:25 pmRNSAdditional Listing
2nd Nov 20153:27 pmRNSAdditional Listing
30th Oct 20151:20 pmRNSDirector Declaration
27th Oct 20157:00 amRNSDirectorate Change
21st Oct 20151:57 pmRNSTotal Voting Rights
13th Oct 201512:23 pmRNSDirector/PDMR Shareholding
9th Oct 201511:47 amRNSDoc re. Key Dates
9th Oct 201510:57 amRNSAdditional Listing
5th Oct 201511:47 amRNSHolding(s) in Company
28th Sep 20152:00 pmRNSAcquisition
16th Sep 201511:07 amRNSDirector/PDMR Shareholding
15th Sep 20153:42 pmRNSTotal Voting Rights - Replacement
15th Sep 20153:02 pmRNSTotal Voting Rights
9th Sep 201512:00 pmRNSCompliance with Model Code
8th Sep 201511:45 amRNSHolding(s) in Company
28th Aug 201510:18 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.